EP300 调节 CD8br AC (TBNK 面板) 以促进失眠
1Department of Anesthesiology, Hangzhou Women's Hospital (Hangzhou Maternity and Child Health Care Hospital, Hangzhou First People's Hospital Qianjiang New City Campus, Zhejiang Chinese Medical University), Hangzhou, 310008, China.
Molecular neurobiology
|July 8, 2025
概括
这项研究确定EP300是一种与乳相关的基因,与失眠有关. 通过影响免疫细胞,EP300可能会促进失眠,为睡眠障碍提供潜在的新治疗点.
科学领域:
- 遗传学 遗传学 是一个
- 睡眠医学 睡眠医学
- 免疫学 免疫学 免疫学
背景情况:
- 失眠是一种常见的疾病,受多种因素的影响.
- 乳化相关基因在失眠病原体中的作用尚不清楚.
研究的目的:
- 为了研究乳化相关基因与失眠之间的因果关系.
- 为了确定失眠的潜在治疗点.
主要方法:
- 使用cis表达量的特征位置 (cis-eQTL) 数据进行门德尔随机化分析.
- 通过基于总结数据的MR (SMR) 和基因表达综合 (Geo) 数据分析进行验证.
- 涉及免疫细胞和EP300基因表达的调解分析.
主要成果:
- 一个与乳化相关的基因EP300显著与失眠有关.
- 在失眠患者和健康个体之间,EP300表达有显著差异.
- 似乎EP300通过调节CD8br AC (TBNK面板) 免疫细胞来促进失眠.
结论:
- EP300与失眠的病原发生有关.
- EP300代表了一种潜在的新型治疗点,用于治疗失眠.
相关概念视频
Management of Insomnia
327
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
327
Sedatives and Hypnotics Drugs: Miscellaneous Agents
247
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
247
Insomnia
132
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
132
CNS Depressants: Barbiturates and Benzodiazepines
478
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
478
Substance Use Disorders Affecting Sleep
225
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
225


